Cargando…

Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review

INTRODUCTION: Randomized controlled trials (RCTs) of biologics in patients with severe, uncontrolled asthma have shown differential results by baseline blood eosinophil count (BEC). In the absence of head-to-head trials, we describe the effects of biologics on annualized asthma exacerbation rate (AA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korn, Stephanie, Cook, Bill, Simpson, Lisa J., Llanos, Jean-Pierre, Ambrose, Christopher S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272272/ https://www.ncbi.nlm.nih.gov/pubmed/37233876 http://dx.doi.org/10.1007/s12325-023-02514-0

Ejemplares similares

Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review
por: Bernstein, Jonathan A., et al.
Publicado: (2023)

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
por: Menzies-Gow, Andrew, et al.
Publicado: (2023)

Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma
por: Park, Hae-Sim, et al.
Publicado: (2019)

Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP
por: De Corso, Eugenio, et al.
Publicado: (2022)

Rapid effect of benralizumab in fulminant eosinophilic myocarditis in the setting of uncontrolled eosinophilic asthma
por: Goyack, Laura, et al.
Publicado: (2023)

Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
por: Li, Jiang-Hua, et al.
Publicado: (2021)

Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
por: Kayser, Moritz Z, et al.
Publicado: (2021)

Incremental cost burden among patients with severe uncontrolled asthma in the United States
por: Burnette, Autumn, et al.
Publicado: (2023)

Shared genetic architecture of blood eosinophil counts and asthma in UK Biobank
por: Li, Boyang, et al.
Publicado: (2023)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
por: Chapman, Kenneth R., et al.
Publicado: (2019)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
por: Gao, Jie, et al.
Publicado: (2018)

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
por: George, Leena, et al.
Publicado: (2019)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
por: Laidlaw, Tanya M, et al.
Publicado: (2023)

Characteristics of patients with severe, uncontrolled, eosinophilic asthma enrolled in a French cohort
por: Aubier, Michel, et al.
Publicado: (2018)

A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment
por: Davison, John, et al.
Publicado: (2021)

Prevalence of Asthma and COPD and Blood Eosinophil Count in a Middle-Aged Belgian Population
por: Wijnant, Sara R. A., et al.
Publicado: (2019)

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma
por: Gao, Jie, et al.
Publicado: (2018)

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2021)

Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency
por: Korn, Stephanie, et al.
Publicado: (2013)

The Biology of Eosinophils and Their Role in Asthma
por: McBrien, Claire N., et al.
Publicado: (2017)

Differences in hospital admissions for acute exacerbations of COPD during the COVID-19 pandemic stratified by stable-state blood eosinophil count
por: Aung, Hnin, et al.
Publicado: (2023)

Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
por: Humbert, Marc, et al.
Publicado: (2018)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
por: Song, Jin Hwa, et al.
Publicado: (2017)

Serum Vitamin D Is Inversely Associated with Blood Eosinophil Count Among Adults with Allergic Asthma
por: Hernández-Colín, Dante Daniel, et al.
Publicado: (2023)

Characteristics of patients with asthma overprescribed short-acting beta-agonist (SABA) reliever inhalers stratified by blood eosinophil count in North East London: a cross-sectional observational study
por: Pfeffer, Paul, et al.
Publicado: (2023)

Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
por: Jackson, David J., et al.
Publicado: (2020)

Association Between Clinical Burden and Blood Eosinophil Counts in Asthma: Findings From a Korean Adult Asthma Cohort
por: Kim, Mi-Yeong, et al.
Publicado: (2022)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
por: Prazma, Charlene M., et al.
Publicado: (2019)

Changes in Peripheral Blood Eosinophil Counts and Risk of Eosinophilic Granulomatosis with Polyangiitis Onset after Initiation of Dupilumab Administration in Adult Patients with Asthma
por: Kushima, Yoshitomo, et al.
Publicado: (2023)

Determination of sputum eosinophil count and serum absolute eosinophil count in patients with bronchial asthma and its correlation with disease severity and response to treatment
por: Mangattu Parambil, Princia Banu, et al.
Publicado: (2023)

Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma–COPD overlap
por: Takayama, Yusuke, et al.
Publicado: (2018)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
por: Price, David B., et al.
Publicado: (2019)

Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma
por: O’Quinn, Sean, et al.
Publicado: (2019)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST
por: Maspero, Jorge F., et al.
Publicado: (2021)

Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma
por: Choi, Youngwoo, et al.
Publicado: (2018)

Comparison of omalizumab and mepolizumab treatment efficacy in patients with atopic and eosinophilic “Overlap” severe asthma: Biological agent preference in atopic-eosinophilic severe asthma
por: Tepetam, Fatma Merve, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iols4j2ois9sb30l4ga0ur2e7n